Official Publications OSE Immunotherapeutics

Equities

Market Closed - Euronext Paris Other stock markets 11:35:19 2024-05-09 am EDT			After market 12:05:26 pm
7 ^EUR	+5.11%		7	0.00%

Apr. 17	OSE: licensing agreement with AbbVie enters into force	CF
Apr. 17	OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie	MT

Mixed general Shareholders meeting notice	May. 05	CO
Universal registration document	May. 01	CO
Monthly statement on voting rights	Apr. 02	CO
Annual results	Mar. 26	CO
Annual results	Mar. 26	CO
Monthly statement on voting rights	Feb. 28	CO
Threshold crossings	Feb. 05	CO
Security operations	Feb. 05	CO
Monthly statement on voting rights	Jan. 30	CO
Threshold crossings	Jan. 08	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	23-10-30	CO
Monthly statement on voting rights	23-09-29	CO
1st-half-year results	23-09-26	CO
Half-year report	23-09-26	CO
Monthly statement on voting rights	23-08-30	CO
Monthly statement on voting rights	23-06-29	CO
Shareholders meeting voting results	23-06-21	CO
Monthly statement on voting rights	23-05-30	CO
Mixed general Shareholders meeting notice	23-05-14	CO
Monthly statement on voting rights	23-04-29	CO
Auditors Report	23-04-27	CO
Universal registration document	23-04-27	CO
Monthly statement on voting rights	23-03-30	CO